Literature DB >> 32955067

Promising nanomaterials in the fight against malaria.

Livia Neves Borgheti-Cardoso1, María San Anselmo2, Elena Lantero1, Alexandre Lancelot2, José Luis Serrano2, Silvia Hernández-Ainsa3, Xavier Fernàndez-Busquets1, Teresa Sierra2.   

Abstract

For more than one hundred years, several treatments against malaria have been proposed but they have systematically failed, mainly due to the occurrence of drug resistance in part resulting from the exposure of the parasite to low drug doses. Several factors are behind this problem, including (i) the formidable barrier imposed by the Plasmodium life cycle with intracellular localization of parasites in hepatocytes and red blood cells, (ii) the adverse fluidic conditions encountered in the blood circulation that affect the interaction of molecular components with target cells, and (iii) the unfavorable physicochemical characteristics of most antimalarial drugs, which have an amphiphilic character and can be widely distributed into body tissues after administration and rapidly metabolized in the liver. To surpass these drawbacks, rather than focusing all efforts on discovering new drugs whose efficacy is quickly decreased by the parasite's evolution of resistance, the development of effective drug delivery carriers is a promising strategy. Nanomaterials have been investigated for their capacity to effectively deliver antimalarial drugs at local doses sufficiently high to kill the parasites and avoid drug resistance evolution, while maintaining a low overall dose to prevent undesirable toxic side effects. In recent years, several nanostructured systems such as liposomes, polymeric nanoparticles or dendrimers have been shown to be capable of improving the efficacy of antimalarial therapies. In this respect, nanomaterials are a promising drug delivery vehicle and can be used in therapeutic strategies designed to fight the parasite both in humans and in the mosquito vector of the disease. The chemical analyses of these nanomaterials are essential for the proposal and development of effective anti-malaria therapies. This review is intended to analyze the application of nanomaterials to improve the drug efficacy on different stages of the malaria parasites in both the human and mosquito hosts.

Entities:  

Year:  2020        PMID: 32955067     DOI: 10.1039/d0tb01398f

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  6 in total

1.  Potent Virustatic Polymer-Lipid Nanomimics Block Viral Entry and Inhibit Malaria Parasites In Vivo.

Authors:  Adrian Najer; Joshua Blight; Catherine B Ducker; Matteo Gasbarri; Jonathan C Brown; Junyi Che; Håkon Høgset; Catherine Saunders; Miina Ojansivu; Zixuan Lu; Yiyang Lin; Jonathan Yeow; Omar Rifaie-Graham; Michael Potter; Renée Tonkin; Jelle Penders; James J Doutch; Athina Georgiadou; Hanna M G Barriga; Margaret N Holme; Aubrey J Cunnington; Laurence Bugeon; Margaret J Dallman; Wendy S Barclay; Francesco Stellacci; Jake Baum; Molly M Stevens
Journal:  ACS Cent Sci       Date:  2022-05-03       Impact factor: 18.728

2.  Fluorescent Nitrogen-Doped Carbon Dots for Label Live Elder Blood-Stage Plasmodium falciparum through New Permeability Pathways.

Authors:  Jiahui Xu; Fengyue Hu; Shuang Li; Jiaojiao Bao; Yi Yin; Zhenyu Ren; Ying Deng; Fang Tian; Guangyu Bao; Jian Liu; Yinyue Li; Xinlong He; Juqun Xi; Feng Lu
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

Review 3.  A review on nanostructured silver as a basic ingredient in medicine: physicochemical parameters and characterization.

Authors:  Gabriel M Misirli; Kishore Sridharan; Shirley M P Abrantes
Journal:  Beilstein J Nanotechnol       Date:  2021-05-14       Impact factor: 3.649

4.  Functionalized Boron Nanoparticles as Potential Promising Antimalarial Agents.

Authors:  Yinghuai Zhu; Parichat Prommana; Narayan S Hosmane; Paolo Coghi; Chairat Uthaipibull; Yingjun Zhang
Journal:  ACS Omega       Date:  2022-02-09

Review 5.  Review of the Current Landscape of the Potential of Nanotechnology for Future Malaria Diagnosis, Treatment, and Vaccination Strategies.

Authors:  Arnau Guasch-Girbau; Xavier Fernàndez-Busquets
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

6.  Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens.

Authors:  Md Tanjir Islam; Mei-Fong Ho; Ummey J Nahar; Ahmed O Shalash; Prashamsa Koirala; Waleed M Hussein; Danielle I Stanisic; Michael F Good; Mariusz Skwarczynski; Istvan Toth
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.